| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |